You are here

Near-infrared Diffuse Optical Imaging for Noninvasive Monitoring of Cortical Spreading Depression

Award Information
Agency: Department of Defense
Branch: Army
Contract: W81XWH-06-C-0408
Agency Tracking Number: A064-028-0229
Amount: $749,962.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: A06-T028
Solicitation Number: N/A
Timeline
Solicitation Year: 2006
Award Year: 2007
Award Start Date (Proposal Award Date): 2007-09-11
Award End Date (Contract End Date): 2008-09-09
Small Business Information
20 New England Business Center
Andover, MA 01810
United States
DUNS: 073800062
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Nicusor Iftimia
 Prnicipal Research Scientist
 (978) 689-0003
 iftimia@psicorp.com
Business Contact
 B. Green
Title: President, R&D Operations
Phone: (978) 689-0003
Email: green@psicorp.com
Research Institution
 MASSACHUSETTS GENERAL HOSPITAL
 Barbara Steele
 
50 Staniford Street 10th Floor, Suite 1001
Boston, MA 2114
United States

 (617) 724-2725
 Domestic Nonprofit Research Organization
Abstract

Cortical spreading depression (CSD) is a region of transient electrical and metabolic failure that propagates through peri-lesional brain tissue. Although characteristics of CSD have been shown to be relevant to injury outcome, subdural electrode measurements, currently in use, restrict monitoring only to patients requiring craniotomy. A portable, noninvasive monitoring device applicable to all patients experiencing CSD would therefore be of great clinical utility from the standpoint of furthering our basic understanding as well as guiding treatment strategies. Physical Sciences Inc. and Massachusetts General Hospital have developed under DOD funding a time-domain near-infrared device to monitor CSD noninvasively. Phase I studies have demonstrated the capability of this instrument for monitoring CSD in a piglet model. Phase II research will focus on the engineering aspects that will allow for device miniaturization, as well as for enhanced temporal and spatial resolution. This new system will be validated in human patients by conducting a clinical pilot study at the Massachusetts General Hospital on a population affected by stroke and/or TBI. The new compact prototype device will have a low-profile probe that will not interfere with normal patient care. This device will also be robust and suitable for field deployment.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government